+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound deficiencies in multiple fibroblast growth factor signalling components differentially impact the murine gonadotrophin-releasing hormone system



Compound deficiencies in multiple fibroblast growth factor signalling components differentially impact the murine gonadotrophin-releasing hormone system



Journal of Neuroendocrinology 22(8): 944-950



Gonadotrophin-releasing hormone (GnRH) neurones control the onset and maintenance of fertility. Aberrant development of the GnRH system underlies infertility in Kallmann syndrome [KS; idiopathic hypogonadotropic hypogonadism (IHH) and anosmia]. Some KS patients harbour mutations in the fibroblast growth factor receptor 1 (Fgfr1) and Fgf8 genes. The biological significance of these two genes in GnRH neuronal development was corroborated by the observation that GnRH neurones were severely reduced in newborn transgenic mice deficient in either gene. In the present study, we hypothesised that the compound deficiency of Fgf8 and its cognate receptors, Fgfr1 and Fgfr3, may lead to more deleterious effects on the GnRH system, thereby resulting in a more severe reproductive phenotype in patients harbouring these mutations. This hypothesis was tested by counting the number of GnRH neurones in adult transgenic mice with digenic heterozygous mutations in Fgfr1/Fgf8, Fgfr3/Fgf8 or Fgfr1/Fgfr3. Monogenic heterozygous mutations in Fgfr1, Fgf8 or Fgfr3 caused a 30-50% decrease in the total number of GnRH neurones. Interestingly, mice with digenic mutations in Fgfr1/Fgf8 showed a greater decrease in GnRH neurones compared to mice with a heterozygous defect in the Fgfr1 or Fgf8 alone. This compounding effect was not detected in mice with digenic heterozygous mutations in Fgfr3/Fgf8 or Fgfr1/Fgfr3. These results support the hypothesis that IHH/KS patients with digenic mutations in Fgfr1/Fgf8 may have a further reduction in the GnRH neuronal population compared to patients harbouring monogenic haploid mutations in Fgfr1 or Fgf8. Because only Fgfr1/Fgf8 compound deficiency leads to greater GnRH system defect, this also suggests that these fibroblast growth factor signalling components interact in a highly specific fashion to support GnRH neuronal development.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269034

Download citation: RISBibTeXText

PMID: 20553372

DOI: 10.1111/j.1365-2826.2010.02024.x


Related references

Effect of growth hormone releasing hormone on plasma growth hormone in relation to magnitude and duration of growth hormone deficiency in 26 children and adults with isolated growth hormone deficiency or multiple pituitary hormone deficiencies evidence for hypothalamic growth hormone releasing hormone deficiency. Journal of Clinical Endocrinology & Metabolism 58(6): 1043-1049, 1984

Fibroblast growth factor receptors 1 and 2 are differentially regulated in murine embryonal carcinoma cells and in response to fibroblast growth factor-4. Journal of Cellular Physiology 165(2): 438-448, 1995

Fibroblast growth factor deficiencies impact anxiety-like behavior and the serotonergic system. Behavioural Brain Research 264: 74-81, 2014

Fibroblast growth factor 8 signaling through fibroblast growth factor receptor 1 is required for the emergence of gonadotropin-releasing hormone neurons. Endocrinology 149(10): 4997-5003, 2008

Fibroblast growth factor signalling in the hair growth cycle: expression of the fibroblast growth factor receptor and ligand genes in the murine hair follicle. Developmental Dynamics 205(4): 379-386, 1996

Differential effects of basic fibroblast growth factor, epidermal growth factor, transforming growth factor-alpha, and insulin-like growth factor-I on a hypothalamic gonadotropin-releasing hormone neuronal cell line. Journal of Neuroscience Research 49(6): 739-749, 1997

Smad proteins are targets of transforming growth factor beta1 in immortalised gonadotrophin-releasing hormone releasing neurones. Journal of Neuroendocrinology 17(11): 753-760, 2005

Role of fibroblast growth factor signaling in gonadotropin-releasing hormone neuronal system development. Frontiers of Hormone Research 39: 37-50, 2010

Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin. Fertility and Sterility 95(6): 2034-2038, 2011

Immortalized hypothalamic luteinizing hormone-releasing hormone (LHRH) neurons induce a functional switch in the growth factor responsiveness of astroglia: involvement of basic fibroblast growth factor. International Journal of Developmental Neuroscience 18(8): 743-763, 2001

Effects of gonadotrophin surge-attenuating factor on the two pools of gonadotrophin-releasing hormone-induced luteinizing hormone secretion in vitro. Human Reproduction 8(6): 822-828, 1993

Human hypothalamic growth hormone releasing factor evidence for 2 forms identical to tumor derived growth hormone releasing factor 44 amide and growth hormone releasing factor 40. Biochemical & Biophysical Research Communications 114(3): 930-936, 1983

Human pancreatic growth hormone releasing factor growth hormone releasing factor 1 29 amide and rat growth hormone releasing factor 3 40 hydroxide alter the activity of neurons in rat amygdala. Society for Neuroscience Abstracts 11(2): 967, 1985

Multiple follicular growth under pulsatile gonadotrophin releasing hormone stimulation. Human Reproduction 8 Suppl 2: 189-192, 1993

Growth hormone and somatomedin c stimulation in idiopathic growth hormone deficient adults by pulsatile administration of growth hormone releasing factor human pancreatic tumor growth hormone releasing factor 40. Clinical Research 31(5): 869A, 1983